According to these studies, one receptor binding site includes two polar residues Glu96 and Asn104 on bFGF whereas the other includes four hydrophobic residues Tyr24, Tyr103, Leu140 and Met142. Using a protein modelling technique, we report here the identification of a new hydrophobic patch on bFGF which includes residues Tyr73, Val88 and Phe93. The role of this area on receptor binding affinity was evaluated by mutating each of these residues individually and determining the mutated protein's (mutein's) receptor binding affinity. In addition, we examined the role of two other hydrophobic residues, Phe30 and Leu138, on bFGF for high-affinity receptor binding. These two residues are the neighbors of the hydrophobic residues Tyr24 and Tyr103, respectively. Replacement of Val88 and Phe93 with alanine reduced the receptor binding affinity about 10-and 80-fold, respectively, compared with wild-type bFGF. In contrast, substitution of Phe30 and Leu138 with alanine has no effect on the receptor binding affinities. We conclude that the newly identified hydrophobic residues, Val88 and Phe93, are crucial for the receptor binding. The present data, together with the previous identification of four hydrophobic residues (Tyr24, Tyr103, Leu140 and Met142), suggests that there are two hydrophobic receptor binding sites on the bFGF surface. Our findings can be employed in the discovery and design of potent bFGF antagonists using computational methods.
Introduction
Members of the bFGF family are thought to play an important role in the pathology of tumor growth (Folkman, 1985) , wound healing (Folkman and Klagsburn, 1987) , rheumatoid disease (Melnyk et al., 1990) and diabetic retinopathy (Sivalingam et al., 1990) . To date, 12 members of the FGF family have been identified (Verdier et al., 1997) . DNA sequencing of members of this gene family has revealed that they possess 30-55% identity at the primary amino acid sequence level (Dionne et al., 1990) .
Recently, high and low affinity receptor binding sites on the bFGF surface have been identified by employing structure based site-directed mutagenesis (Springer et al., 1994; Zhu et al., 1995 Zhu et al., , 1997 . According to these studies, the high affinity site on bFGF includes four hydrophobic residues Tyr24, Tyr103, Leu140 and Met142 and two polar residues Glu96 and Asn104 on bFGF. The low affinity site is composed of amino acids Lys110, Tyr111 and Trp114, which plays an important role in stimulation of mitogenic activity.
Here we report the results of additional site-directed mutagenesis studies on bFGF hydrophobic residues Phe30, Val88, Phe93 and Leu138. Residues Tyr73, Val88 and Phe93 form a hydrophobic patch on the bFGF surface, which is about 10-15 Å away from the low affinity site and 20-23 Å away from the high affinity site. Residues Phe30, Phe31 and Leu138 are the neighbouring residues of Tyr24 and Tyr103, part of the high affinity receptor binding site. All residues were found to be solvent accessible (ASA Ͼ 10 Å 2 ). Replacement of Phe31 with alanine has been shown by Springer et al. (1994) to have no effect on the receptor binding affinity and was thus not included in the site-directed mutagenesis study. All other residues were individually mutated to alanine. All the muteins but Y73A were found to be partially soluble in the cytoplasm when expressed in bacteria. Subsequently soluble mutants were purified to near homogeneity employing a heparinSepharose column followed by a CM-Sepharose column. The binding affinity of the bFGF muteins to soluble FGFR1β-TPA fusion protein was determined and compared with wildtype bFGF.
Materials and methods

Materials
Human synthetic bFGF gene was purchased from R&D Systems (Minneapolis, MN). Expression vector pET11d and bacterial strain BL21(DE3) were obtained from Novagen (Madison, WI). Baculovirus transfection vector PVL1393 was obtained from PharMingen (San Diego, CA). Magic mini preparation kit was obtained from Promega (Madison, WI). Heparin-Sepharose was obtained from Pharmacia LKB Biotechnology, Inc. (Piscataway, NJ). Heparin was purchased from Sigma (St Louis, MO). FGFR1β-TPA fusion protein was a gift from Eisai Corporation (Tsukuba, Japan). 125 I-bFGF was obtained from NEN Research Products (Boston, MA). AntibFGF monoclonal antibody was purchased from Upstate Biotechnology, Inc. Alkaline phosphatase-conjugated anti-mouse Ig antibodies were purchased from BioRad (Hercules, CA). Prestained protein molecular weight standards were purchased from Gibco/BRL (Gaithersburg, MD). All other chemicals were of reagent grade, purchased from Sigma.
Molecular dynamics calculations
The crystal structure of bFGF was obtained from the protein data bank (Koetzle et al., 1977; Abola et al., 1987) (code 3FGF) and analyzed computationally as described previously (Zhu et al., 1995) . Briefly, we added hydrogen atoms to these initial coordinates, and minimized the system to relieve repulsive steric interactions. To evaluate solvent effects on the protein, its geometric center was determined and a spherical shell of water of 26 Å radius was placed around it to completely immerse it in a spherical water bath. The total size of the solvated protein system was 5444 atoms. A dielectric constant of 4.0 was used in the calculations. Three stages of minimization were carried out on the system prior to the dynamics simulations. Initially, only the solvent around the protein was minimized for 500 cycles to optimize the interactions between the solvent molecules. In the second stage, 500 iterations of minimization were carried out for the total solvent/protein system to optimize the interaction between the solvent and protein. Finally, the whole system was minimized again with the SHAKE option (Ryckert et al., 1977) , to constrain the bonds in the system. The molecular dynamics simulation was carried out at 300 K and 1 atm pressure. After 50 ps of equilibration, data were collected every picosecond over a period of 500 ps. Each conformer obtained at 25 ps intervals was minimized and stored for further analysis. The computations were performed using an extensively modified version (Ramnarayan et al., 1990) of the AMBER program (Singh et al., 1986) . The timeaveraged conformations resulting from the molecular dynamics calculations were analyzed to derive information for the sitedirected mutagenesis studies.
Identification of residues for mutagenesis
Of the 124 residues in bFGF, those that are solvent accessible were identified using solvent accessibility calculations based on the algorithm published earlier (Chothia, 1974) on the dynamic average structure. All hydrophobic residues on the bFGF surface were identified and classified into groups based on their proximity to each other. Hydrophobic residues Tyr73, Val88 and Phe93 are close to each other within 4.5-6.0 Å radius and form a hydrophobic patch which is about 10-15 Å away from the low affinity binding site and 20-30 Å away from the high affinity binding site. Hydrophobic residues Phe30, Phe31 and Leu138 are within the 5 Å radius from their closest high affinity binding residues. All identified hydrophobic residues are fully solvent accessible and targeted for site-directed mutagenesis.
Gene construction and site-directed mutagenesis
Synthetic bFGF gene was digested with NcoI and BamHI restriction enzymes and subcloned into pET11d vector containing T7 promoter. Site-directed mutagenesis was carried out following the Clontech method. Briefly, pET11d coding for bFGF was denatured and annealed with a BamHI unique selection primer and the desired mutation primers. After elongation and ligation, the mutagenic plasmid was digested 938 with BamHI for 1 h at 37°C and transformed into BMH 71-18 mut S E.coli strains for in vivo plasmid amplification. The amplified DNA was purified with magic mini preparation kit and digested with BamHI again for the second round selection. The digested mixture was then transformed into DH5a E.coli strain. The desired mutation was confirmed by the dideoxy DNA sequencing method prior to protein expression. Expression and purification of wild-type bFGF or muteins from E.coli Expression vectors were transformed into the BL21(DE3) E.coli strain. Cultures were grown to an OD 600 of 0.8 in LB medium containing 40 mg/ml ampicillin at 37°C, and bFGF expression was induced by adding 0.4 mM IPTG to further culture at 37°C in a thermoshaker for 4 h. The bFGF containing cell culture was then pelleted by centrifugation and lysed according to standard procedures (Seno et al., 1990) . The cytoplasmic fraction containing the mutein was loaded onto a heparin-Sepharose column equilibrated with buffer containing 0.6 M NaCl, 25 mM Tris-HCl, pH 7.5. After extensively washing the column with 25 mM Tris-HCl (pH 7.5) containing 1 M NaCl, proteins were eluted with 25 mM Tris-HCl (pH 7.5) containing 2 M NaCl. The purified protein fractions were run on 12% SDS-PAGE and stained with Coomassie Blue R-250. The concentration and purity of proteins were determined with a scanning densitometer using bovine serum albumin as a standard.
Soluble receptor binding assay
Binding assays were performed essentially as described previously (Zhu et al., 1995) . Briefly, soluble receptor FGFR1β-TPA fusion protein was coated onto a 96-well plate and incubated overnight at 4°C. The plate was then blocked with buffer containing 0.5% gelatin, 100 mM NaCl and 25 mM HEPES, pH 7.5, and incubated at room temperature for 1 h. For the competition assay, the soluble receptor FGFR1β-TPAcoated plate was incubated with binding buffer containing 125 IbFGF (1-20 ng/ml) and 2 µg/ml heparin in the presence of varied concentrations of unlabeled bFGF or its muteins. After incubation for 3 h at room temperature, plates were washed twice with phosphate-buffered saline containing 2 M NaCl, and the radioactivity determined. Non-specific binding was determined in parallel binding experiments using a 1000-fold excess unlabeled bFGF.
Results
We previously identified Glu96 and Asn104 as two crucial residues for high affinity receptor binding (Zhu et al., 1995 (Zhu et al., , 1997 . Here we report the identification of a new hydrophobic patch on the bFGF surface and examine the role of solvent accessible hydrophobic residues on receptor binding affinity. In addition, we explored the neighbouring hydrophobic residues of the high affinity binding site on the bFGF surface, based on the molecular dynamics refined structure of bFGF (Eriksson et al., 1991 (Eriksson et al., , 1993 Zhang et al., 1991; Zhu et al., 1991) (Figure 1 ). The ASA (accessible surface area) of each residue was calculated based on a published algorithm (Chothia, 1974) . It was found to be solvent accessible (Ͼ10 Å 2 ) and was subjected to site-directed mutagenesis. The resulting muteins were then compared with wild-type bFGF for their receptor binding affinity to soluble FGFR1β-TPA fusion protein.
Site-directed mutagenesis of Tyr73, Val88 and Phe93
Analysis of the molecular dynamics refined structure of bFGF indicates that hydrophobic residues Tyr73, Val88 and Phe93 are close to each other within 4.5-6.0 Å radius and form a hydrophobic patch on the bFGF surface (Figure 1 ). All three residues are solvent accessible (Table I) . To evaluate whether these residues were involved in affinity binding to FGF receptor, we individually replaced each residue with alanine and determined the receptor binding affinity of the resulting mutein using a radiolabeled receptor competition assay. V88A and F93A muteins were partially soluble and could be purified to homogeneity using a heparin-Sepharose column, followed by a CM-Sepharose column. Substitution of Phe93 by alanine reduced receptor binding affinities by approximately 80-fold compared with wild-type bFGF (Table I) . When Val88 was replaced by an alanine a 10-fold reduction on receptor binding affinity was observed compared with the wild-type bFGF ( Table I ). The Y73A mutein was confined to inclusion bodies, and attempts to refold the inclusion bodies were unsuccessful.
Site-directed mutagenesis of Phe30 and Leu138
To explore further potentially critical hydrophobic residues near the high affinity receptor binding site on bFGF, we identified the hydrophobic residues Phe30 neighboring Tyr24 within 5 Å radius, and the hydrophobic residue Leu138 neighboring Tyr103 within 5 Å radius (Figure 1 ). Both residues are solvent accessible (Table I) . To evaluate whether Phe30 and Leu138 are involved in high affinity receptor binding, we The relative affinity is the ratio of IC 50 values calculated from the competitive binding of 125 I-labeled bFGF and unlabeled wild-type bFGF or bFGF muteins, respectively, to the soluble FGFR1β-TPA fusion protein (average of two experiments). L138A denotes the bFGF mutein in which the leucine residue at position 138 is replaced by alanine. All IC 50 values were determined using commercially available software Prizm. The IC 50 value for wild-type bFGF is 0.52 nMϮ0.05 nM.
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replaced each with alanine and determined the receptor binding affinity of the resulting muteins using a radiolabeled receptor competition assay. Replacement of Phe30 and Leu138 with alanine had little effect on receptor binding affinity ( Table I) , suggesting that these residues are not important for the high affinity receptor binding.
Discussion
Structure-based site-directed mutagenesis studies by Springer et al. (1994) and Zhu et al. (1995 Zhu et al. ( , 1997 showed the primary high-affinity FGF receptor binding site to be the four hydrophobic amino acids (Tyr24, Tyr103, Leu140 and Met142) and two polar amino acids (Glu96 and Asn104). In the present work, we carried out site-directed mutagenesis based on the dynamic structure of bFGF to evaluate a newly identified hydrophobic patch composed of Tyr73, Val88 and Phe93, and the hydrophobic residues Phe30 and Leu138 in the neighborhood of Tyr24 and Tyr103, for affinity binding to FGF receptor. Replacement of Val88 and Phe93 with alanine gave muteins with reduced receptor binding affinities of about 10-fold and 80-fold, respectively, compared with the wild-type protein. The Y73A mutein was found to be insoluble in the cytoplasm when expressed in bacteria. By contrast, substitution of residues Phe30 and Leu138 by alanine gave muteins with little effect on the receptor binding affinity, compared with the wild-type protein.
To evaluate whether the loss of receptor binding affinity of F93A and V88A was due to the effect of heparin on the FGF-FGFR interaction, we considered the following evidence. First, the heparin-bFGF interaction has been shown to involve a number of residues of bFGF by site-directed mutagenesis and X-ray crystallographic approaches. Neither Val88 nor Phe93 is involved in interaction with heparin Faham et al., 1996) . Second, V88A and F93A bind to heparinSepharose and can be eluted from a heparin-Sepharose column with 2 M NaCl buffer, suggesting that replacement of Val88 and Phe93 by alanine does not significantly affect heparin affinity and that there are no global conformational changes in the V88A and F93A muteins.
In our previous studies, bFGF muteins, E96A, N104A, Y103A and L140A, reduced receptor binding affinities more than 200-fold, whereas K110A, Y111A and W114A gave less than 10-fold reduction of the receptor binding affinities (Zhu et al., 1995 (Zhu et al., , 1997 Springer et al., 1994) . Since replacement of either Val88 or Phe93 with alanine reduced the receptor binding affinity in the range between 10-and 100-fold, we define that Val88 and Phe93 contribute medium affinity binding to FGF receptor.
Site-directed mutagenesis studies on FGFR show that the active core of the receptor (the loop II, the inter-loop II/III sequence, the N-terminus of loop III and glycosaminoglycan) can bind to acidic fibroblast growth factor (aFGF), bFGF and KGF (Wang et al., 1995) . The high conservation of residues Tyr24, Glu96, Tyr103, Asn104 and Leu140 in these factors suggests that they bind to this active core of the receptor. Sitedirected mutagenesis on bFGF and modeling of FGF receptor also indicate that the low affinity site composed of Lys110, Tyr111 and Trp114 may interact with receptor binding domains on the front of loop III (Seddon et al., 1995; Wang et al., 1995) . Hydrophobic residues, Val88 and Phe93 are a medium affinity receptor binding site and about 10-15 Å away from the low affinity site and 20-30 Å away from the high affinity site. How this new identified hydrophobic patch on bFGF interacts with FGF receptor is unknown and has to await either a modeling study or the determination of the three dimensional X-ray structure of the bFGF-FGFR complex.
The new hydrophobic residues identified here for the FGF receptor binding elucidates the importance of the hydrophobic cluster on the surface of a molecule for protein-protein association. These results suggest that the surface hydrophobic patch can be used to identify regions of a protein's surface most likely to interact with its receptor. This is critical for the structure-based design of small molecule antagonists.
